Access to HealthEnvironmental SustainabilityEmployeesEthics Transparency

Our Business

Economic
Impact

Economic
Impact
Our Business

Long-term business success depends on making relevant, quality products through sustainable and ethical practices.

Globalization and the expanding reach of firms during the past decade have escalated expectations that multinational enterprises will create more social value, beyond just regulatory compliance and philanthropic contributions. Corporate responsibility has evolved to be an important element of the private sector’s response to these expectations.

While it can be seen as a way to improve one’s reputation, or simply as a response to a moral imperative to do good, we believe that corporate responsibility is critical to our business success and can provide us with new opportunities to create shared value. Our principal economic contribution to society is made through the discovery, development, manufacturing and marketing of our products, which directly improve and maintain the health of individuals and communities around the world, helping them to lead more productive lives.

For additional information about our business and economic performance, please see our Form 10-K for the year ended December 31, 2015.

 

2015 REVENUES BY GEOGRAPHIC REGION (IN BILLIONS)
  • U.S.: 44%

  • Europe, Middle East
    and Africa:
    27%

  • Asia
    Pacific:
    10%

  • Japan: 7%

  • Latin America: 7%

  • Other: 5%

Total 2015 Revenue: $39.5

PRODUCT SALES (IN MILLIONS)
  • Pharmaceutical: 88%

  • Animal Health: 8%

  • Consumer Care1: 0%

  • Other Revenues2: 4%

Total Sales: $39,498

Financial Information     
20112012201320142015
Sales (in millions)$48,047$47,267$44,033$42,237$39,498
Research and development expenses (in millions)1$8,467$8,168$7,503$7,180$6,704
Number of employees86,00083,00077,00070,00068,000
Number of stockholders of record166,100157,400149,400142,000135,500
Annual cash dividend paid per share$1.56$1.69$1.73$1.77$1.81
Global tax expense as reported on income statement (in millions)$942$2,440$1,028$5,349$942
1 Excludes restructuring and merger-related expenses